The reported 8,000 confirmed and 60,000 suspected measles cases in Bangladesh underscore failures in sustaining high coverage of the second measles-containing vaccine dose, a pattern observed in observational cohort studies across South Asia where two-dose completion rates hover below 80 percent in rural districts. An analysis of Demographic and Health Survey data (observational, n=12,500 households, no conflicts declared) links these gaps to supply chain disruptions rather than outright refusal, contrasting with RCT evidence from similar settings showing 95 percent efficacy when delivery is consistent. Coverage of the initial NYT reporting omitted how post-COVID catch-up drives in neighboring India and Pakistan produced transient reductions followed by resurgence within 18 months, per WHO surveillance reports. Peer-reviewed modeling in The Lancet Infectious Diseases (observational geospatial analysis, sample covering 1.2 million children) predicts that without integrating measles into primary care incentives, Bangladesh risks annual outbreaks exceeding 50,000 cases. This connects to broader under-vaccinated clusters where vitamin A deficiency amplifies case fatality ratios by 2-3 fold in under-resourced areas.